HOME >> MEDICINE >> NEWS
Higher doses of cancer drug imatinib proven effective and safe

ortance as previous studies of another cancer drug (interferon alpha) have shown that CCR is associated with a 70 to 80 percent chance of 10-year survival, a positive prospect as the survival time for newly diagnosed CML patients is typically about five years.

Another measure of successful treatment is the number of patients with complete molecular response, occurring when the levels of BCR-ABL are so low that they are undetectable using a highly sensitive method called polymerase chain reaction. In past studies, patients who had undetectable levels of BCR-ABL after treatment have not relapsed after long-term follow up. In high-dose therapy patients, the incidence of complete molecular response was 28 percent compared to only seven percent of patients taking the standard dosage of imatinib.

"The high rates of complete cytogenetic and molecular response that we've seen in this study are unprecedented. If such responses have similar long-term significance as seen in previous studies, this translates into a major improvement in the prognosis of patients with CML," states Hagop Kantarjian, M.D., chairman of the Department of Leukemia at M. D. Anderson Cancer Center and the lead author of the study.

Researchers found that the high dosage of imatinib was generally well tolerated, with a similar rate of side effects as standard dose imatinib. To reduce more severe side effects, the dosage of imatinib was lowered to 600 mg or 400 mg daily for some patients, though a majority remained at the target dosage.

The disease did not transform beyond the chronic phrase in any of the study patients, and 98 percent had a complete hematologic response, meaning the number of white blood cells was no longer out of control and the signs and symptoms of leukemia were gone.

The results of the study indicate that patients in the early stage of this cancer may benefit from higher doses of the drug imatinib in their initial treatment to safely and effe
'"/>

Contact: Aislinn Raedy
araedy@hematology.org
202-776-0544
American Society of Hematology
1-Apr-2004


Page: 1 2 3

Related medicine news :

1. Higher folate intake associated with decreased risk of hypertension in women
2. Higher incidence of rejection following early steroid withdrawal
3. Higher radiation doses help some lung cancer patients live longer
4. Higher dose of Gleevec leads to increased remission in CML patients
5. Higher education or larger brain size may protect against dementia later in life, new study finds
6. Higher cost sharing reduces plans drug expenditures, but boosts enrollee costs
7. Higher nocturnal blood pressure predictive of kidney disease in diabetes
8. First quarter 2002 prescription drug spending: Higher again, but rate of increase drops
9. Higher rate of improvement, lower rate of adverse effects with clarithromycin for acute exacerbations of chronic bronchitis
10. Cancer Rates In Children Of Nuclear Industry Employees No Higher Than General Population In England And Wales
11. New Study Finds Blacks Face 38 Percent Higher Stroke Risk

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Higher doses cancer drug imatinib proven effective and safe

(Date:7/22/2014)... Garland’s new Energizer BK specially ... as a flood coat over new and existing asphalt ... restoration material. It provides natural resistance to moisture, chemicals, ... life-cycle costs. Energizer BK is specially formulated with an ... in addition to superior strength and flexibility. , ...
(Date:7/22/2014)... UT (PRWEB) July 22, 2014 Most people encounter ... is a weak appetite and the second is a fast metabolism. ... CB-1 Weight Gainer provides ways to help fight these problems ... of appetite. There are people out there who just can’t seem ... bites and then they are full. The cause of this problem ...
(Date:7/22/2014)... CA (PRWEB) July 22, 2014 The ... training, olympic weightlifting, plyometrics, powerlifting, gymnastics, kettleball lifting, calisthenics, ... workout. , Jason Sobzcak, co-owner of CrossFit ... EnergyFirst’s products because extreme workouts like these require ... Paleo diet so I need to take in about ...
(Date:7/21/2014)... (PRWEB) July 22, 2014 Recently, Stwd.co.uk, a ... of cheap wedding dresses. Additionally, the company’s chief executive officer ... at discounted prices, up to 58% off. , “All our ... The special offer is launched to bring huge benefits to ... collection of cheap wedding outfits. By the way, we offer ...
(Date:7/21/2014)... 2014 PowerObjects, a professional services ... and add-ons for Microsoft Dynamics CRM, has joined ... elite group of the most strategic Microsoft Dynamics ... that rank them in the highest echelon of ... of the Microsoft Dynamics Inner Circle have performed ...
Breaking Medicine News(10 mins):Health News:Energizer® BK Waterproof Coating from Garland Canada Reduces Life-Cycle Costs 2Health News:CB-1 Weight Gainer Provides Two Tips to Help Customers Gain Weight 2Health News:CrossFit East Cobb Fuels Their Intense Workouts with All-Natural EnergyFirst Supplements 2Health News:CrossFit East Cobb Fuels Their Intense Workouts with All-Natural EnergyFirst Supplements 3Health News:2014 Cheap Wedding Dresses, Newest Items Offered by Professional Company Stwd.co.uk 2Health News:PowerObjects Joins the 2014 Microsoft Dynamics Inner Circle 2
(Date:7/21/2014)... , July 21, 2014 McCord Research, ... (U.S. Patent No. 8,796,315). This patent describes a ... healing.  According to the inventor, Dr. McCord, this ... require wound healing, a composition of an effective ... from umbilical cord blood, such that the administration ...
(Date:7/21/2014)... -- Nitrosolution.com, a website that features safe and all-natural ... anniversary in August. The online retailer specializes in an ... ability to produce nitric oxide. Called Nitroxyl, it is ... variety of phytonutrients and other natural ingredients that a ... nitric oxide production in the arteries and brain. ...
(Date:7/21/2014)... , July 21, 2014  Champions Oncology (OTC: ... technology solutions and services to personalize the development and ... its financial and operational results for the fourth quarter ... July 24, 2014, after market close. The ... results that day at 4:30 p.m. EDT (1:30 p.m. ...
Breaking Medicine Technology:US Patent Office Grants McCord Research Endothelial Cell Treatment Patent 2Up and Coming Nitric Oxide Supplements Company Nitrosolution.com Celebrates its One Year Anniversary 2
Cached News: